DAy 3
Liposomal Amphotericin B Treatment initiated*
Rashid's antifungal therapy was changed to Liposomal
Amphotericin B (3 mg/kg/day).** Empiric antibiotics
were also started for his S. maltophilia infection.
Amphotericin B (3 mg/kg/day).** Empiric antibiotics
were also started for his S. maltophilia infection.
An upper digestive tract endoscopy was performed
to place an oesophageal prosthesis and repeated three
days later to check for any leakage. A computerised
tomography (CT) scan showed no evidence of leakage
of oral contrast medium.
to place an oesophageal prosthesis and repeated three
days later to check for any leakage. A computerised
tomography (CT) scan showed no evidence of leakage
of oral contrast medium.
*Please refer to the Summary of Product Characteristics of your chosen
treatment prior to prescribing.
treatment prior to prescribing.
**Administration of a test dose is advisable before a new course of Liposomal
Amphotericin B treatment. Therapy is usually started at a daily dose of
1.0 mg/kg and increased stepwise to 3.0 mg/kg as required.12
Amphotericin B treatment. Therapy is usually started at a daily dose of
1.0 mg/kg and increased stepwise to 3.0 mg/kg as required.12
Why Liposomal Amphotericin B
Decision point
